Skip to main content
SpringerLink
Log in

Myositis: a rare but potentially life-threatening condition

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zilko PJ, Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: optimum immunosuppressive treatment. BioDrugs 1997 Apr; 7(4): 262–72

    Article  PubMed  CAS  Google Scholar 

  2. Joffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med 1993; 94: 379–87

    Article  PubMed  CAS  Google Scholar 

  3. Nuki G. Diseases of connective tissues, joints and bones. In: Edwards CRW, Bouchier IAD, Haslett C, et al., editors. Davidson’s principles and practice of medicine. 17th ed. London: Churchill Livingston, 1995: 863–940

    Google Scholar 

  4. Davies DM, editor. Textbook of adverse drug reactions. 4th ed. Oxford: Oxford University Press, 1991

    Google Scholar 

  5. Cherin P. Recognition and management of myositis. Drugs 1997 Jul; 54(1): 39–49

    Article  PubMed  CAS  Google Scholar 

  6. Fukunaga H, Osane M, Sakashita I, et al. Clinical and physiopathological findings in polymyositis. No To Shinkei (Japan) 1987; 39: 657–61

    CAS  Google Scholar 

  7. Leff RL, Miller FW, Hicks J, et al. The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine (Baltimore) 1993; 72: 225–35

    CAS  Google Scholar 

  8. Cherin P, Herson S, Godeau P. Physiopathogénie des dermatomyosites et des polymyosites: mise au point. Ann Med Interne 1990; 141: 156–9

    CAS  Google Scholar 

  9. O’Leary PA, Waisman M. Dermatomyositis: a study of 40 cases. Arch Dermatol Syphilol 1940; 41: 1001–94

    Article  Google Scholar 

  10. Henriksson KG, Sandstedt P. Polymyositis treatment and prognosis: a study of 107 patients. Acta Neurol Scand 1982; 65: 280–300

    Article  PubMed  CAS  Google Scholar 

  11. Uchino M, Araki S, Yoshida O, et al. High single dose alternate day corticosteroid regimens in treatment of polymyositis. J Neurol 1985; 232: 175–8

    Article  PubMed  CAS  Google Scholar 

  12. Yanagisawa T, Sueishi M, Nawata Y, et al. Methylprednisolone pulse therapy in dermatomyositis. Dermatological 1983; 167: 47–51

    Article  CAS  Google Scholar 

  13. Laxer RM, Stein LD, Petty RE. Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis. Arthritis Rheum 1987; 30: 328–34

    Article  PubMed  CAS  Google Scholar 

  14. Oddis CV, Medsger Jr TA. Relationship between serum creatine kinase level and corticosteroid therapy in polymyositisdermatomyositis. J Rheumatol 1988; 15: 807–11

    PubMed  CAS  Google Scholar 

  15. Oddis CV, Hill P, Medsger Jr TA. Functional outcome in a national cohort of polymyositis-dermatomyositis patients [abstract]. Arthritis Rheum 1992; 35: S88

    Article  Google Scholar 

  16. British National Formulary. No. 34. London: The Pharmaceutical Press, 1997 Sep

  17. Miller F, Leitman SF, Cronin ME, et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992; 326: 1380–2

    Article  PubMed  CAS  Google Scholar 

  18. Cherin P, Piette JC, Wechsler B, et al. Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11 cases. J Rheumatol 1994; 21: 1092–7

    PubMed  CAS  Google Scholar 

  19. Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993; 20: 1340–4

    PubMed  CAS  Google Scholar 

  20. Bennington JL, Dau PC. Patients with polymyositis and dermatomyositis who undergo plasmapheresis therapy. Arch Neurol 1981; 38: 553–60

    Article  PubMed  CAS  Google Scholar 

  21. Woo TY, Callen JP, Voorhees JJ, et al. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 1984; 10: 592–600

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Myositis: a rare but potentially life-threatening condition. Drugs Ther. Perspect 11, 5–9 (1998). https://doi.org/10.2165/00042310-199811090-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199811090-00002

Keywords

Search

Navigation